Showing results (181-190 of 252) with videos related to
Sort By:
Pageof 26
Hepatology Communications|May 10, 2024
Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitisZobair M Younossi, Kamal Kant Mangla, Tina Landsvig Berentzen, et al.Resuscitation|February 8, 2018
Coronary angiographic findings and outcomes in patients with sudden cardiac arrest without ST-elevation myocardial infarction: A SWEDEHEART studyAxel Wester, Moman A Mohammad, Pontus Andell, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 10, 2018
Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countriesMagnus Holmer, Espen Melum, Helena Isoniemi, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 23, 2026
Risk of CKD in biopsy-proven metabolic dysfunction-associated steatotic liver diseaseFahim Ebrahimi, Christian Eichhorn, Tracey G Simon, et al.Hepatology Communications|July 14, 2025
Diabetes mellitus in alcohol-associated liver disease: Prevalence and outcomesBen Ward, Mark Theodoreson, Guruprasad Aithal, et al.Frontiers in Immunology|June 20, 2019
Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver DiseaseNatalie Stiglund, Kristina Strand, Martin Cornillet, et al.Journal of Clinical Medicine|November 24, 2020
Risk of Developing Pancreatic Cancer in Patients with Chronic PancreatitisMiroslav Vujasinovic, Ana Dugic, Patrick Maisonneuve, et al.Journal of Internal Medicine|July 3, 2024
Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLDHannes Hegmar, Thomas Wiggers, Patrik Nasr, et al.Alimentary Pharmacology & Therapeutics|March 9, 2024
Prevalence and risk factors of metabolic dysfunction-associated steatotic liver disease in south Central Uganda: A cross-sectional surveyRocio Enriquez, Mahmoud Homsi, Robert Ssekubugu, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 26, 2026
Prevalence and Risk Factors of Elevated Alanine Aminotransferase (ALT) in 2382 Treatment-naïve HBV/HDV Co-Infected PatientsHabiba Kamal, Ganbolor Jargalsaikhan, Sanjaasuren Enkhtaivan, et al.Pageof 26